Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Accelerated vaccination schedule effective for Lyme disease

June 10, 1999

Inhibitex obtains license to MSCRAMM from University of Minnesota

June 8, 1999

New bone marrow transplant technique looks promising

June 8, 1999

Fludarabine and other specific STAT1-targeting drugs as potential immunosuppressants

June 7, 1999

Wyeth Lederle Vaccines submits PLA for pneumococcal vaccine

June 7, 1999

Interferon inducers in development at Hokuriku Seiyaku

June 7, 1999

Licensing opportunity from Cornell Research Foundation: methods of modulating immune responses

June 7, 1999

New class of triterpene immunosuppressants described by Merck

June 4, 1999

Coulter acquires therapeutic antibody from Pharma Pacific

June 4, 1999

Merck presents new class of potassium channel blockers and immunosuppressants

June 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...